Title

A review of paraoxonase 1 properties and diagnostic applications

Journal title

Polish Journal of Veterinary Sciences

Yearbook

2016

Issue

No 1

Authors

Kulka, M.

Divisions of PAS

Nauki Biologiczne i Rolnicze

Publisher

Polish Academy of Sciences Committee of Veterinary Sciences ; University of Warmia and Mazury in Olsztyn

Date

2016

Identifier

DOI: 10.1515/pjvs-2016-0028 ; ISSN 1505-1773

Source

Polish Journal of Veterinary Sciences; 2016; No 1

References

Aldrige (1953), Serum esterases Two types of esterases and hydrolysing p - nitrophenyl acetate , propionate and butyrate and a method for their determination, Biochem J, 53, 110, doi.org/10.1042/bj0530110 ; Miyamoto (2005), Bovine paraoxonase activites in serum and distribution in lipoproteins, J Vet Med Sci, 67. ; Azarsiz (2003), PON activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease, Int J Cardiol, 91, 43, doi.org/10.1016/S0167-5273(02)00595-8 ; Deakin (2002), Enzymatically active paraoxonase - is located at the external membrane of producing cells and released by a high affinity , saturable , desorption mechanism, J Biol Chem, 277. ; Kulka (2014), Serum paraoxonase - activity of dairy Holstein - Fresian cows in different lactation stages - preliminary study, Pol J Vet Sci, 17, 143. ; Sorenson (1995), The genetic mapping and gene structure of mouse paraoxonase / arylesterase, Genomics, 30, 431, doi.org/10.1006/geno.1995.1261 ; Juretic (2006), Paraoxonase / arylesterase in serum of patients with type II diabetes mellitus, Acta Pharm, 56, 59. ; Navab (2001), HDL and the Inflammatory Response Induced by LDL - Derived Oxidized Phospholipids, Arterioscler Thromb Vasc Biol, 21, 481, doi.org/10.1161/01.ATV.21.4.481 ; Cao (1999), Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q - - R genetic polymorphism, J Lipid Res, 40, 133. ; Eckerson (1983), The human serum paraoxonase / arylesterase polymorphism, Am J Hum Genet, 35, 1126. ; Aviram (1998), Paraoxonase inhibits high - density lipoprotein oxidation and preserves its functions A possible peroxidative role for paraoxonase, J Clin Invest, 101, 1581, doi.org/10.1172/JCI1649 ; Lusis (2000), Atherosclerosis, Nature, 407. ; Gugliucci (2013), Enzymatic assessment of paraoxonase activity on HDL subclasses : a practical zymogram method to assess HDL function, Clin Chim Acta, 415. ; Jain (2011), Acute - phase proteins : As diagnostic tool, J Pharm Bioallied Sci, 3, 118, doi.org/10.4103/0975-7406.76489 ; Karabina (2005), Oxidative inactivation of paraoxonase - - implications in diabetes mellitus and atherosclerosis, Biochim Biophys Acta, 1725. ; Shih (2000), Combined serum paraoxonase knockout / apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis, J Biol Chem, 275. ; Sözmen (2001), Catalase / superoxide dismutase ( SOD ) and catalase / paraoxonase PON ratios may implicate poor glycemic control, Arch Med Res, 32, 283, doi.org/10.1016/S0188-4409(01)00285-5 ; Li (2000), Catalytic efficiency determines the in - vivo efficiency of PON for detoxifying organophosphorus compounds, Pharmacogenetics, 10, 767, doi.org/10.1097/00008571-200012000-00002 ; Kappelle (2011), Lower serum paraoxonase - activity is related to higher serum amyloid a levels in metabolic syndrome, Arch Med Res, 42, 219, doi.org/10.1016/j.arcmed.2011.05.002 ; Edmonson (1989), A Body Condition Scoring chart for Holstein Dairy Cows, J Dairy Sci, 72, 69, doi.org/10.3168/jds.S0022-0302(89)79081-0 ; Camps (2012), PPARs in regulation of paraoxonases : control of oxidative stress and inflammation pathways, PPAR Res, 616371. ; Turk (2004), Serum paraoxonase activity and lipid parameters in the early postpartum period of dairy cows, Vet Res Sci, 76, 57, doi.org/10.1016/j.rvsc.2003.08.001 ; Tsuzura (2004), Correlation of plasma oxidized low - density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type diabetes, Metabolism, 2. ; Gan (1991), Purification of human serum paraoxonase / arylesterase Evidence for one esterase catalyzing both activities, Drug Metab Dispos, 19, 100. ; Jaouad (2003), PON paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity Free, Radic Res, 37. ; Van Lenten (1995), de Beer Anti - inflammatory HDL becomes pro - inflammatory during the acute phase response Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures, J Clin Invest, 96, 2758, doi.org/10.1172/JCI118345 ; Feingold (1998), Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response, Atherosclerosis, 139. ; Gaidukov (2010), ApoE induces serum paraoxonase PON activity and stability similar to ApoA - I, Biochemistry, 49, 532, doi.org/10.1021/bi9013227 ; Farid (2013), Serum paraoxonase - as biomarker for improved diagnosis of fatty liver in dairy cows, BMC Vet Res, 9, 73, doi.org/10.1186/1746-6148-9-73 ; Bionaz (2007), Plasma paraoxonase , health inflammatory conditions and liver function in trasition dairy cows, J Dairy Sci, 90, 1740, doi.org/10.3168/jds.2006-445 ; Ferretti (2004), Protective effect of paraoxonase activity in high - density lipoproteins against erythrocyte membranes peroxidation : a comparison between healthy subjects and type diabetic patients, J Clin Endocrinol Metab, 89, 2957, doi.org/10.1210/jc.2003-031897 ; Draganov (2005), Human paraoxonases and are lactonases with overlapping and distinct substrate specificities, J Lipid Res, 46, 1239, doi.org/10.1194/jlr.M400511-JLR200 ; Mackness (2004), Paraoxonase - inhibits oxidised LDL - induced MCP - production by endothelial cells, Biochem Biophys Res Commun, 318. ; Mackness (1988), Multiple forms of sheep serum A - esterase activity associated with the high - density lipoprotein, Biochem J, 250. ; Deakin (2011), HDL - associated paraoxonase - can redistribute to cell membranes and influence sensitivity to oxidative stress Free, Radic Biol Med, 50, 102, doi.org/10.1016/j.freeradbiomed.2010.09.002 ; Bergmeier (2004), Distribution spectrum of paraoxonase activity in HDL fractions, Clin Chem, 50, 2309, doi.org/10.1373/clinchem.2004.034439 ; Aviram (1998), Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different that required for its arylesterase / paraoxonase activities : selective action of human paraoxonase allozymes Q and R, Arterioscler Thromb Vasc Biol, 18, 1617, doi.org/10.1161/01.ATV.18.10.1617 ; Méndez (2014), Acute phase response in dogs with Dirofilaria immitis, Vet Parasitol, 204. ; Rosenson (2011), HDL measures , particle heterogeneity , proposed nomenclature , and relation to atherosclerotic cardiovascular events, Clin Chem, 57, 392, doi.org/10.1373/clinchem.2010.155333 ; Aviram (2004), Paraoxonases oxidative stress , and macrophage foam cell formation during atherosclerosis development Free, Radic Biol Med, 37, 1304, doi.org/10.1016/j.freeradbiomed.2004.06.030 ; Steinberg (1997), Lewis A Conner Memorial Lecture Oxidative modification of LDL and atherogenesis, Circulation, 95, 1062, doi.org/10.1161/01.CIR.95.4.1062 ; Nobecourt (2005), Defective antioxidative activity of small dense HDL particles in type diabetes : relationship to elevated oxidative stress and hyperglycaemia, Diabetologia, 48, 2, doi.org/10.1007/s00125-004-1655-5 ; Khovidhunkit (2000), Infection and inflammation - induced proatherogenic changes of lipoproteins S, J Infect Dis, 181. ; Gewurz (1982), C - reactive protein and the acute phase response, Adv Intern Med, 27, 345. ; Roche (2000), Reproductive management of postpartum cows, Anim Reprod Sci, 60, 703, doi.org/10.1016/S0378-4320(00)00107-X ; Bauchart (1993), Lipid Absorption and Transport in Ruminants, J Dairy Sci, 76, 3864, doi.org/10.3168/jds.S0022-0302(93)77728-0 ; Rozenberg (2003), Paraoxonase deficiency is associated with increased macrophage oxidative stress : studies in PON - knockout mice Free, Radic Biol Med, 34, 774, doi.org/10.1016/S0891-5849(02)01429-6 ; Nguyen (2003), Oxidative inactivation of paraoxonase - an antioxidant protein and its effect on antioxidant action Free, Radic Res, 37, 1319, doi.org/10.1080/5760310001621351-1 ; Antončić (2011), Lipid status , paraoxonase - activity and metabolic parameters in serum of heifers and lactating cows related to oxidative stress, Res Vet Sci, 90, 298, doi.org/10.1016/j.rvsc.2010.05.022 ; Aviram (1999), Does paraoxonase play a role in susceptibility to cardiovascular disease, Mol Med Today, 5, 381, doi.org/10.1016/S1357-4310(99)01546-4 ; Erzengin (2014), Purification and characterization of paraoxonase from Swiss Black Holstein and Montofon bovines, Appl Biochem Biotechnol, 173. ; Carr (2015), Species differences in paraoxonase mediated hydrolysis of several organophosphorus insecticide metabolites, J Toxicol, 2015. ; Billecke (2000), Human serum paraoxonase isozymes Q and R hydrolyze lactones and cyclic carbonate esters, Drug Metab Dispos, 28, 1335. ; Van Lenten (2001), High - density lipoprotein loses its anti - inflammatory properties during acute influenza A infection, Circulation, 103, 2283, doi.org/10.1161/01.CIR.103.18.2283 ; Watson (2001), Rabbits possess a serum paraoxonase polymorphism similar to the human, Pharmacogenetics, 11, 192, doi.org/10.1097/00008571-200103000-00003 ; Kulka (2016), Serum paraoxonase activity and lipid metabolism parameters changes in different production cycle periods of Holstein - Friesian , Polish Red and Norwegian breeds, Pol J Vet Sci, 19, 165. ; Schuller (2011), Lack of efficacy of low - dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs, J Vet Pharmacol Ther, 34, 322, doi.org/10.1111/j.1365-2885.2010.01235.x ; Novak (2010), Decreased paraoxonase activity in critically ill patients with sepsis, Clin Exp Med, 10, 21, doi.org/10.1007/s10238-009-0059-8